Monoclonal Immunoglobulin Deposition Disease

hematologic malignancy

Identifier: CI-CAN-00006049
Entity page: /cancer/monoclonal-immunoglobulin-deposition-disease ↗
Edges: 184

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Monoclonal Immunoglobulin Deposition Disease investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 36show all (up to 200)
→ investigated in trials for	Dexamethasonesmall molecule 31 trials (9 active) · roll-up of the cancer and its descendants	—	—	Monoclonal Immunoglobulin Deposition Disease	31	Observed	clinicaltrials	graph →
→ investigated in trials for

Monoclonal Immunoglobulin Deposition Disease studied in …STUDIED_INderived10 of 148show all (up to 200)
→ studied in	NCT06768489Phase 1 · recruiting A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma · condition mapped ALIAS · 148 trials mapped (54 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07172243recruiting BE.Amycon Biobank & Data Registry UZ Leuven · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active)	—	—	Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT05283993recruiting A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active)	—	—	Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07215494NA · recruiting A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis · condition mapped ALIAS · 148 trials mapped (54 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07103863enrolling by invitation Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07615270early Phase 1 · not yet recruiting A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT05145816Phase 1/Phase 2 · recruiting Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT06569147Phase 1/Phase 2 · recruiting Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT07751471Phase 2 · not yet recruiting BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004) · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active)	—	—	AL Amyloidosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT01169337Phase 3 · active not recruiting Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma · condition mapped ONTOLOGY_EXACT · 148 trials mapped (54 active)	—	—	Light Chain Deposition Disease	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains